Untangling the relationship between diet and visceral fat mass through blood metabolomics and gut microbiome profiling

Metformin is the first-line pharmacotherapy for treating type 2 diabetes mellitus (T2DM); however, its mechanism of modulating glucose metabolism is elusive. Recent advances have identified the gut as a potential target of metformin. As patients with metabolic disorders exhibit dysbiosis, the gut microbiome has garnered interest as a potential target for metabolic disease. Henceforth, studies have focused on unraveling the relationship of metabolic disorders with the human gut microbiome. According to various metagenome studies, gut dysbiosis is evident in T2DM patients. Besides this, alterations in the gut microbiome were also observed in the metformin-treated T2DM patients compared to the non-treated T2DM patients. Thus, several studies on rodents have suggested potential mechanisms interacting with the gut microbiome, including regulation of glucose metabolism, an increase in short-chain fatty acids, strengthening intestinal permeability against lipopolysaccharides, modulating the immune response, and interaction with bile acids. Furthermore, human studies have demonstrated evidence substantiating the hypotheses based on rodent studies. This review discusses the current knowledge of how metformin modulates T2DM with respect to the gut microbiome and discusses the prospect of harnessing this mechanism in treating T2DM.

Download Full-text

AP2-microRNA-26a overexpression reduces visceral fat mass and blood lipids

Molecular and Cellular Endocrinology ◽

10.1016/j.mce.2021.111217 ◽

2021 ◽

pp. 111217

Author(s):

Hailuan Zeng ◽

Weihong Sun ◽

Xinping Ren ◽

Nan Xia ◽

Sheng Zheng ◽

...

Keyword(s):

Fat Mass ◽

Visceral Fat ◽

Blood Lipids

Download Full-text

Seasonal Shifts in Cold Tolerance and the Composition of the Gut Microbiome of Dendroctonus valens LeConte Occur Concurrently

Forests ◽

10.3390/f12070888 ◽

2021 ◽

Vol 12 (7) ◽

pp. 888

Author(s):

Zehai Hou ◽

Yaxin Dong ◽

Fengming Shi ◽

Yabei Xu ◽

Sixun Ge ◽

...

Keyword(s):

Antioxidant Enzyme ◽

Cold Tolerance ◽

Gut Microbiome ◽

Antioxidant Enzyme Activities ◽

Severe Damage ◽

Geographic Ranges ◽

Dendroctonus Valens ◽

Different Seasons ◽

The Relationship ◽

Seasonal Shifts

Dendroctonus valens LeConte, an invasive bark beetle, has caused severe damage in pine forests and has the potential to disperse into new geographic ranges in China. Although the gut microbiota of D. valens and its fundamental role in host fitness have been investigated widely, little is known about the relationship between the seasonal shifts of both cold tolerance and the gut microbiome of D. valens during overwintering, which occurs at the larval stage. In this study, to examine seasonal variations in the composition of the microbiome, we collected D. valens larvae in September (autumn), January (winter), and May (spring), and then analyzed the bacterial and fungal communities of the gut via sequencing of partial 16S rRNA and ITS genes. In addition, changes in the supercooling capacity and antioxidant enzyme activities of D. valens larvae collected in the different seasons were evaluated. Overwintering resulted in changes to microbial communities. In particular, the abundances of Enterobacter, Serratia, Erwinia, and Klebsiella decreased during overwintering. Concurrent with these changes, the cold tolerance of D. valens larvae was enhanced during overwintering, and the activities of the antioxidant enzymes catalase and peroxidase were reduced. We hypothesize that seasonal shifts in the gut microbiome may be connected to changes in cold tolerance and antioxidant enzyme activity in D. valens. It will be worthwhile to confirm whether seasonal changes in the microbiome contribute to the success of host overwintering.

Download Full-text

Relationship between Visceral Fat and PAI-1 in Overweight Men and Women before and after Weight Loss

Thrombosis and Haemostasis ◽

10.1055/s-0037-1614860 ◽

1999 ◽

Vol 82 (11) ◽

pp. 1490-1496 ◽

Cited By ~ 35

Author(s):

M. Kockx ◽

R. Leenen ◽

J. Seidell ◽

H. M. G. Princen ◽

T. Kooistra

Keyword(s):

Weight Loss ◽

Fat Mass ◽

Visceral Fat ◽

Linear Regression Analysis ◽

Energy Deficit ◽

Obese Women ◽

Plasminogen Activator Inhibitor 1 ◽

Men And Women ◽

Total Fat ◽

Pai 1

SummaryThis study was aimed at evaluating the relationship between visceral fat accumulation and plasma plasminogen activator inhibitor-1 (PAI-1) levels in healthy, obese men and women undergoing weight loss therapy. The subjects, 25 men and 25 premenopausal women, aged between 26 and 49 years, with an initial body mass index between 28 and 38 kg/m2, received a controlled diet for 13 weeks providing a 4.2 MJ/day energy deficit. Magnetic resonance imaging was used to measure visceral and subcutaneous abdominal fat. Our results show that before weight loss visceral fat was significantly correlated with PAI-1 in men (r = 0.45; p <0.05), but not in women (r = -0.15; ns). The association between visceral fat and PAI-1 in men remained significant after adjustment for age and total fat mass, and multiple linear regression analysis showed a significant independent contribution of visceral fat to plasma PAI-1 levels. Both visceral fat areas and PAI-1 levels decreased significantly with weight loss in both men and women. Changes in visceral fat area were related to changes in PAI-1 in women (r = -0.43; p = 0.05) but not in men (r = -0.01; ns); however, this association in women disappeared after adjustment for total fat mass. We conclude that there is a relationship between visceral fat and PAI-1 in obese men but not in obese women, and that PAI-1 levels decrease substantially (52%) by weight loss, but this change is not related to changes in visceral fat mass per se.

Download Full-text

Association between Serum Concentration of Carotenoid and Visceral Fat

Nutrients ◽

10.3390/nu13030912 ◽

2021 ◽

Vol 13 (3) ◽

pp. 912

Author(s):

Mai Matsumoto ◽

Hiroyuki Suganuma ◽

Naoki Ozato ◽

Sunao Shimizu ◽

Mitsuhiro Katashima ◽

...

Keyword(s):

Cardiovascular Diseases ◽

Visceral Fat ◽

Fruits And Vegetables ◽

Beta Carotene ◽

The Body ◽

Healthy Individuals ◽

Health Checkup ◽

Visceral Fat Area ◽

The Relationship ◽

Aomori Prefecture

Consumption of fruits and vegetables rich in carotenoids has been widely reported to prevent cardiovascular diseases. However, the relationship between serum carotenoid concentrations and visceral fat area (VFA), which is considered a better predictor of cardiovascular diseases than the body-mass index (BMI) and waist circumference, remains unclear. Therefore, we examined the relationship in healthy individuals in their 20s or older, stratified by sex and age, to compare the relationship between serum carotenoid concentrations and VFA and BMI. The study was conducted on 805 people, the residents in Hirosaki city, Aomori prefecture, who underwent a health checkup. An inverse relationship between serum carotenoid concentrations and VFA and BMI was observed only in women. In addition, the results were independent of the intake of dietary fiber, which is mainly supplied from vegetables as well as carotenoids. This suggests that consumption of a diet rich in carotenoids (especially lutein and beta-carotene) is associated with lower VFA, which is a good predictor of cardiovascular disease, especially in women. This study is the first to comprehensively evaluate the association between serum carotenoid levels and VFA in healthy individuals.

Download Full-text

Influence of methyltestosterone postmenopausal therapy on plasma lipids, inflammatory factors, glucose metabolism and visceral fat: a randomized study

Acta Endocrinologica ◽

10.1530/eje.1.02065 ◽

2006 ◽

Vol 154 (1) ◽

pp. 131-139 ◽

Cited By ~ 18

Author(s):

Lenora M Camarate S M Leão ◽

Mônica Peres C Duarte ◽

Dalva Margareth B Silva ◽

Paulo Roberto V Bahia ◽

Cláudia Medina Coeli ◽

...

Keyword(s):

Risk Factors ◽

Insulin Resistance ◽

Blood Pressure ◽

Cardiovascular Disease ◽

Cardiovascular Risk ◽

Cardiovascular Risk Factors ◽

Postmenopausal Women ◽

Fat Mass ◽

Visceral Fat ◽

Increased Risk

Background: There has been a growing interest in treating postmenopausal women with androgens. However, hyperandrogenemia in females has been associated with increased risk of cardiovascular disease. Objective: We aimed to assess the effects of androgen replacement on cardiovascular risk factors. Design: Thirty-seven postmenopausal women aged 42–62 years that had undergone hysterectomy were prospectively enrolled in a double-blind protocol to receive, for 12 months, percutaneous estradiol (E2) (1 mg/day) combined with either methyltestosterone (MT) (1.25 mg/day) or placebo. Methods: Along with treatment, we evaluated serum E2, testosterone, sex hormone-binding globulin (SHBG), free androgen index, lipids, fibrinogen, and C-reactive protein; glucose tolerance; insulin resistance; blood pressure; body-mass index; and visceral and subcutaneous abdominal fat mass as assessed by computed tomography. Results: A significant reduction in SHBG (P < 0.001) and increase in free testosterone index (P < 0.05; Repeated measures analysis of variance) were seen in the MT group. Total cholesterol, triglycerides, fibrinogen, and systolic and diastolic blood pressure were significantly lowered to a similar extent by both regimens, but high-density lipoprotein cholesterol decreased only in the androgen group. MT-treated women showed a modest rise in body weight and gained visceral fat mass relative to the other group (P < 0.05), but there were no significant detrimental effects on fasting insulin levels and insulin resistance. Conclusion: This study suggests that the combination of low-dose oral MT and percutaneous E2, for 1 year, does not result in expressive increase of cardiovascular risk factors. This regimen can be recommended for symptomatic postmenopausal women, although it seems prudent to perform baseline and follow-up lipid profile and assessment of body composition, especially in those at high risk of cardiovascular disease.

Download Full-text